DiappyMed

DiappyMed is a French tech company currently in the news for its innovative device, "EkiYou." EkiYou utilizes artificial intelligence to calculate the necessary insulin doses for diabetic patients. This development is newsworthy because it offers a potentially more precise and personalized approach to insulin management, which could significantly improve the lives of individuals with diabetes. Coralie Lefevre, the CEO of DiappyMed, recently presented EkiYou on the "French Tech" segment of the "Good Morning Business" program. This appearance highlights the company's efforts to bring its technology to the forefront and showcase its potential impact on healthcare. The development of AI-driven medical devices like EkiYou is relevant in the context of the increasing integration of technology into healthcare solutions and the growing focus on personalized medicine.